8,405 reports of this reaction
2.6% of all INTERFERON BETA 1A reports
#7 most reported adverse reaction
HEADACHE is the #7 most commonly reported adverse reaction for INTERFERON BETA 1A, manufactured by Biogen Inc.. There are 8,405 FDA adverse event reports linking INTERFERON BETA 1A to HEADACHE. This represents approximately 2.6% of all 322,666 adverse event reports for this drug.
Patients taking INTERFERON BETA 1A who experience headache should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HEADACHE is a less commonly reported adverse event for INTERFERON BETA 1A, but still significant enough to appear in the safety profile.
In addition to headache, the following adverse reactions have been reported for INTERFERON BETA 1A:
The following drugs have also been linked to headache in FDA adverse event reports:
HEADACHE has been reported as an adverse event in 8,405 FDA reports for INTERFERON BETA 1A. This does not prove causation, but indicates an association observed in post-market surveillance data.
HEADACHE accounts for approximately 2.6% of all adverse event reports for INTERFERON BETA 1A, making it a notable side effect.
If you experience headache while taking INTERFERON BETA 1A, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.